Flax and flaxseed oil (Linum usitatissimum): A review by the Natural Standard Research Collaboration Journal Article


Authors: Basch, E.; Bent, S.; Collins, J.; Dacey, C.; Hammerness, P.; Harrison, M.; Smith, M.; Szapary, P.; Ulbricht, C.; Vora, M.; Weissner, W.
Article Title: Flax and flaxseed oil (Linum usitatissimum): A review by the Natural Standard Research Collaboration
Abstract: The objective of this study was to evaluate the scientific evidence on flaxseed, including expert opinion, folkloric precedent, history, pharmacology, kinetics/dynamics, interactions, adverse effects, toxicology, and dosing. Electronic searches were conducted in 9 databases, 20 additional journals (not indexed in common databases), and bibliographies from 50 selected secondary references. No restrictions were placed on the language or quality of the publications. All literature collected pertained to efficacy in humans, dosing, precautions, adverse effects, use in pregnancy/lactation, interactions, alteration of laboratory assays, and mechanisms of action. Standardized inclusion/exclusion criteria are used for selection. Grades were assigned using an evidence-based grading rationale. A review of the literature on flaxseed yielded 13 categories for which flaxseed had been studied in humans, including constipation/laxative, attention-deficit hyperactivity disorder, hyperlipidemia, atherosclerosis/coronary artery disease, breast cancer, cyclic mastalgia (breast pain), menopausal symptoms, hyperglycemia/diabetes, hypertension, lupus nephritis, human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS), and prostate cancer. Most of the available evidence investigates the efficacy of alpha-linoleic acid found in flaxseed compared with fish oil, and almost all of the available studies are poor quality. Although flaxseed and flaxseed oil have several promising future uses, the available literature does not support recommendation for any condition at this time.
Keywords: treatment outcome; clinical trial; constipation; diarrhea; hypertension; nonhuman; side effect; unindexed drug; breast cancer; bleeding; publication; abdominal pain; drug hypersensitivity; dyspnea; hyperglycemia; prostate cancer; pruritus; malaise; systematic review; laboratory test; nonsteroid antiinflammatory agent; proton pump inhibitor; atherosclerosis; diabetes mellitus; nausea and vomiting; insulin; glucose blood level; pregnancy; medical literature; antihypertensive agent; antilipemic agent; oral antidiabetic agent; blood pressure; human immunodeficiency virus; omega 3 fatty acid; acquired immune deficiency syndrome; antioxidants; dietary supplements; seizure; weakness; herbaceous agent; fish oil; testosterone blood level; intestine obstruction; coronary artery disease; lipid blood level; oral contraceptive agent; hyperlipidemia; qualitative research; mineral; drug interactions; allergic reaction; hypersensitivity reaction; urticaria; antithrombocytic agent; pharmacology; medical expert; bronchospasm; lactation; paralysis; nose obstruction; menopausal syndrome; nicotinic acid; anticoagulant agent; interactions; herbs and supplements; bibliographic database; drug overdose; linoleic acid; anti-inflammatory agents; mastalgia; lansoprazole; attention deficit disorder; laxative; lupus erythematosus nephritis; iloprost; thrombocyte aggregation; mania; hypericum perforatum extract; intestinal dysmotility; flax; flaxseed; garlic extract; gymnema sylvestre extract; ispagula; kava extract; lignan; linseed oil; lithium; mood stabilizer; uniprost; valerian; crying; hydrorrhea; hypomania; linseed; luteinizing hormone blood level; ocular pruritus; renal protection; sneezing; tachypnea; unstable gait
Journal Title: Journal of the Society for Integrative Oncology
Volume: 5
Issue: 3
ISSN: 1715-894X
Publisher: BC Decker  
Date Published: 2007-06-01
Start Page: 92
End Page: 105
Language: English
DOI: 10.2310/7200.2007.005
PUBMED: 17761128
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 8" - "Export Date: 17 November 2011" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ethan Martin Basch
    180 Basch